Heron Therapeutics reported $-41882000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Amarin AMRN:US USD -3883000 60.92M
Anika Therapeutics ANIK:US USD -6391000 4.48M
Arrowhead Research ARWR:US USD -41794000 40.36M
Eisai 4523:JP JPY 9.46B 11.04B
Emergent Biosolutions EBS:US USD 6.6M 54.9M
Esperion Therapeutics ESPR:US USD -55487000 370K
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Heron Therapeutics HRTX:US USD -41882000 14.48M
Immunogen IMGN:US USD -57790000 19.96M
Insmed INSM:US USD -159998000 29.22M
JAZZ PHA JAZZ:US USD -46767000 464.14M
Merk MRK:US USD 4.89B 560M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Neurocrine Biosciences NBIX:US USD 117.9M 20M
Omeros OMER:US USD -46048000 8.74M
Pacira Pharmaceuticals PCRX:US USD 46.48M 4.25M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Roche Holding ROG:VX 8.85B 3.26B
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Surmodics SRDX:US USD -7095000 1.27M
Ultragenyx Pharmaceutical RARE:US USD -153284000 85.54M
Veracyte VCYT:US USD -3441000 5.43M
Vertex Pharmaceuticals VRTX:US USD 1.2B 122.8M